Corticotropin Tests for Hypothalamic-Pituitary- Adrenal Insufficiency: A Metaanalysis
Context: The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. Objective: Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI. Data Sources: We searched the PubMed database from 1966–2006 for stud...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 93; no. 11; pp. 4245 - 4253 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Oxford University Press
01.11.2008
Copyright by The Endocrine Society Endocrine Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Context: The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial.
Objective: Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI.
Data Sources: We searched the PubMed database from 1966–2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators.
Study Selection: Eligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls.
Data Extraction: We constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios.
Data Synthesis: Patient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as follows: low-dose corticotropin test, 0.92 (95% confidence interval 0.89–0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74–0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P < 0.001).
Conclusions: Low-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations. |
---|---|
AbstractList | Context: The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. Objective: Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI. Data Sources: We searched the PubMed database from 1966–2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators. Study Selection: Eligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls. Data Extraction: We constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios. Data Synthesis: Patient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as follows: low-dose corticotropin test, 0.92 (95% confidence interval 0.89–0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74–0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P < 0.001). Conclusions: Low-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations. The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial.CONTEXTThe diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial.Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI.OBJECTIVEOur objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI.We searched the PubMed database from 1966-2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators.DATA SOURCESWe searched the PubMed database from 1966-2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators.Eligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls.STUDY SELECTIONEligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls.We constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios.DATA EXTRACTIONWe constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios.Patient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as follows: low-dose corticotropin test, 0.92 (95% confidence interval 0.89-0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74-0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P<0.001).DATA SYNTHESISPatient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as follows: low-dose corticotropin test, 0.92 (95% confidence interval 0.89-0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74-0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P<0.001).Low-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations.CONCLUSIONSLow-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations. CONTEXT:The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. OBJECTIVE:Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI. DATA SOURCES:We searched the PubMed database from 1966-2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators. STUDY SELECTION:Eligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls. DATA EXTRACTION:We constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios. DATA SYNTHESIS:Patient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as followslow-dose corticotropin test, 0.92 (95% confidence interval 0.89-0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74-0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P < 0.001). CONCLUSIONS:Low-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations. The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI. We searched the PubMed database from 1966-2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators. Eligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls. We constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios. Patient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as follows: low-dose corticotropin test, 0.92 (95% confidence interval 0.89-0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74-0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P<0.001). Low-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations. Context: The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. Objective: Our objective was to compare standard-dose and low-dose corticotropin tests for diagnosing HPAI. Data Sources: We searched the PubMed database from 1966–2006 for studies reporting diagnostic value of standard-dose or low-dose corticotropin tests, with patient-level data obtained from original investigators. Study Selection: Eligible studies had more than 10 patients. All subjects were evaluated because of suspicion for chronic HPAI, and patient-level data were available. We excluded studies with no accepted reference standard for HPAI (insulin hypoglycemia or metyrapone test) if test subjects were in the intensive care unit or if only normal healthy subjects were used as controls. Data Extraction: We constructed receiver operator characteristic (ROC) curves using patient-level data from each study and then merged results to create summary ROC curves, adjusting for study size and cortisol assay method. Diagnostic value of tests was measured by calculating area under the ROC curve (AUC) and likelihood ratios. Data Synthesis: Patient-level data from 13 of 23 studies (57%; 679 subjects) were included in the metaanalysis. The AUC were as follows: low-dose corticotropin test, 0.92 (95% confidence interval 0.89–0.94), and standard-dose corticotropin test, 0.79 (95% confidence interval 0.74–0.84). Among patients with paired data (seven studies, 254 subjects), diagnostic value of low-dose corticotropin test was superior to standard-dose test (AUC 0.94 and 0.85, respectively; P < 0.001). Conclusions: Low-dose corticotropin test was superior to standard-dose test for diagnosing chronic HPAI, although it has technical limitations. |
Author | Ambrosi, Bruno Maghnie, Mohamad Evans, Arthur T. Abdu, Tariq A. M. Clayton, Richard N. Courtney, C. Hamish Choi, Cheung Hei Rose, Susan R. Villabona, Carmen V. Atkinson, A. Brew Gonc, E. Nazli Soule, Steven G. Tordjman, Karen Kazlauskaite, Rasa |
AuthorAffiliation | John H. Stroger Jr. Hospital of Cook County and Rush Medical College (R.K., A.T.E., C.V.V.), Chicago, Illinois 60612; Walsall Manor Hospital National Health Service Trust (T.A.M.A.), Walsall, WS2 9PS United Kingdom; University of Milan and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato (B.A.), San Donato Milanese 20097, Italy; Regional Centre for Endocrinology and Diabetes (A.B.A., C.H.C.), Royal Victoria Hospital, Belfast BT12 6BA, United Kingdom; Queen Elizabeth Hospital (C.H.C.), Hong Kong Special Administrative Region; Keele University and North Staffordshire Hospital (R.N.C.), Stoke-on-Trent ST4 7QB,United Kingdom; Hacettepe University (E.N.G.), 06100 Ankara, Turkey; IRCCS G. Gaslini (M.M.), University of Genova, 5-16147 Genova, Italy; Cincinnati Children’s Hospital Medical Center and University of Cincinnati (S.R.R.), Cincinnati, Ohio 45229; Christchurch Hospital (S.G.S.), Christchurch, New Zealand; and Institute of Endocrinology, Metabolism, a |
AuthorAffiliation_xml | – name: John H. Stroger Jr. Hospital of Cook County and Rush Medical College (R.K., A.T.E., C.V.V.), Chicago, Illinois 60612; Walsall Manor Hospital National Health Service Trust (T.A.M.A.), Walsall, WS2 9PS United Kingdom; University of Milan and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato (B.A.), San Donato Milanese 20097, Italy; Regional Centre for Endocrinology and Diabetes (A.B.A., C.H.C.), Royal Victoria Hospital, Belfast BT12 6BA, United Kingdom; Queen Elizabeth Hospital (C.H.C.), Hong Kong Special Administrative Region; Keele University and North Staffordshire Hospital (R.N.C.), Stoke-on-Trent ST4 7QB,United Kingdom; Hacettepe University (E.N.G.), 06100 Ankara, Turkey; IRCCS G. Gaslini (M.M.), University of Genova, 5-16147 Genova, Italy; Cincinnati Children’s Hospital Medical Center and University of Cincinnati (S.R.R.), Cincinnati, Ohio 45229; Christchurch Hospital (S.G.S.), Christchurch, New Zealand; and Institute of Endocrinology, Metabolism, and Hypertension (K.T.), Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel |
Author_xml | – sequence: 1 givenname: Rasa surname: Kazlauskaite fullname: Kazlauskaite, Rasa email: rasa_kazlauskaite@rush.edu organization: 1John H. Stroger Jr. Hospital of Cook County and Rush Medical College (R.K., A.T.E., C.V.V.), Chicago, Illinois 60612 – sequence: 2 givenname: Arthur T. surname: Evans fullname: Evans, Arthur T. organization: 1John H. Stroger Jr. Hospital of Cook County and Rush Medical College (R.K., A.T.E., C.V.V.), Chicago, Illinois 60612 – sequence: 3 givenname: Carmen V. surname: Villabona fullname: Villabona, Carmen V. organization: 1John H. Stroger Jr. Hospital of Cook County and Rush Medical College (R.K., A.T.E., C.V.V.), Chicago, Illinois 60612 – sequence: 4 givenname: Tariq A. M. surname: Abdu fullname: Abdu, Tariq A. M. organization: 2Walsall Manor Hospital National Health Service Trust (T.A.M.A.), Walsall, WS2 9PS United Kingdom – sequence: 5 givenname: Bruno surname: Ambrosi fullname: Ambrosi, Bruno organization: 3University of Milan and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato (B.A.), San Donato Milanese 20097, Italy – sequence: 6 givenname: A. Brew surname: Atkinson fullname: Atkinson, A. Brew organization: 4Regional Centre for Endocrinology and Diabetes (A.B.A., C.H.C.), Royal Victoria Hospital, Belfast BT12 6BA, United Kingdom – sequence: 7 givenname: Cheung Hei surname: Choi fullname: Choi, Cheung Hei organization: 3University of Milan and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Donato (B.A.), San Donato Milanese 20097, Italy – sequence: 8 givenname: Richard N. surname: Clayton fullname: Clayton, Richard N. organization: 6Keele University and North Staffordshire Hospital (R.N.C.), Stoke-on-Trent ST4 7QB,United Kingdom – sequence: 9 givenname: C. Hamish surname: Courtney fullname: Courtney, C. Hamish organization: 5Queen Elizabeth Hospital (C.H.C.), Hong Kong Special Administrative Region – sequence: 10 givenname: E. Nazli surname: Gonc fullname: Gonc, E. Nazli organization: 7Hacettepe University (E.N.G.), 06100 Ankara, Turkey – sequence: 11 givenname: Mohamad surname: Maghnie fullname: Maghnie, Mohamad organization: 8IRCCS G. Gaslini (M.M.), University of Genova, 5-16147 Genova, Italy – sequence: 12 givenname: Susan R. surname: Rose fullname: Rose, Susan R. organization: 9Cincinnati Children’s Hospital Medical Center and University of Cincinnati (S.R.R.), Cincinnati, Ohio 45229 – sequence: 13 givenname: Steven G. surname: Soule fullname: Soule, Steven G. organization: 10Christchurch Hospital (S.G.S.), Christchurch, New Zealand – sequence: 14 givenname: Karen surname: Tordjman fullname: Tordjman, Karen organization: 11Institute of Endocrinology, Metabolism, and Hypertension (K.T.), Tel Aviv Sourasky Medical Center, Tel Aviv 64239, Israel |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20849678$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18697868$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ksFvFCEUxompsdvqzbOZxKgXqTxgZhhvm43aJjV6aBNvhGEgy8oOW2DS7H8v0117aJSEEMLve-9773GGTsYwGoReA7kACuTTRl9QQgQmLZBnaAEdr3ELXXuCFoRQwF1Lf52is5Q2hADnNXuBTkE0XSsasUC3qxCz0yHHsHNjdWNSTpUNsbrc70JeK6-2TuOfLk8uq7jH1XKIZlS-uhrTZK3Tzox6_7laVt9NVqq87JNLL9Fzq3wyr47nObr9-uVmdYmvf3y7Wi2vseYdaTEfOAjbD5SLodO9FbVtieb9MGjTaKNE0xtoOAdaWyCdUaxhHUDNqW141wh2jt4f4u5iuJuKd7l1SRvv1WjClGSpsmY1owV8-wTchCkWt0myhwxMMCjUmyM19VszyF1021K0_NuuArw7Aipp5W1Uo3bpkaNEFFvtzNEDp2NIKRordWlfdmHMUTkvgch5dnKj5Tw7Oc-uiD4-ET3m_zfOD_h98NnE9NtP9ybKtVE-ryUpixcreBYAlBsuG9oi-3CQhWn3vwQPf4n9AU9vtFM |
CODEN | JCEMAZ |
CitedBy_id | crossref_primary_10_15406_emij_2018_06_00170 crossref_primary_10_1089_neu_2013_2916 crossref_primary_10_1159_000430815 crossref_primary_10_1007_s13312_019_1507_5 crossref_primary_10_1136_archdischild_2015_308925 crossref_primary_10_1111_cen_14587 crossref_primary_10_1159_000365190 crossref_primary_10_1210_clinem_dgad579 crossref_primary_10_1136_jim_2015_000012 crossref_primary_10_4254_wjh_v7_i8_1112 crossref_primary_10_1038_pr_2017_289 crossref_primary_10_1111_imj_15033 crossref_primary_10_4158_EP10385_ED crossref_primary_10_1016_S1773_035X_09_70249_7 crossref_primary_10_1007_s42000_020_00185_y crossref_primary_10_4158_EP11013_OR crossref_primary_10_1111_j_1365_2265_2009_03542_x crossref_primary_10_1016_j_ando_2012_01_001 crossref_primary_10_1007_s12519_016_0018_x crossref_primary_10_1080_17446651_2022_2023009 crossref_primary_10_1186_s13223_015_0075_z crossref_primary_10_1210_jendso_bvac115 crossref_primary_10_1111_j_1365_2265_2012_04376_x crossref_primary_10_4158_EP14423_OR crossref_primary_10_1016_j_endonu_2013_08_001 crossref_primary_10_3389_fped_2022_981765 crossref_primary_10_1007_s10620_017_4471_8 crossref_primary_10_1016_j_ejca_2012_02_046 crossref_primary_10_1097_MPH_0000000000002784 crossref_primary_10_20945_2359_3997000000493 crossref_primary_10_1016_j_cca_2020_01_029 crossref_primary_10_1016_S1155_1941_11_53092_6 crossref_primary_10_1177_1040638716671978 crossref_primary_10_1177_0009922818825154 crossref_primary_10_1093_ndt_gfz180 crossref_primary_10_1016_j_amjmed_2015_08_021 crossref_primary_10_1111_j_1365_2265_2012_04474_x crossref_primary_10_1111_cen_12397 crossref_primary_10_14309_ajg_0000000000001486 crossref_primary_10_1097_MEG_0000000000002694 crossref_primary_10_1210_js_2017_00198 crossref_primary_10_1097_MED_0b013e328338f608 crossref_primary_10_1111_cen_12150 crossref_primary_10_1016_j_envres_2018_02_041 crossref_primary_10_1530_EJE_17_0251 crossref_primary_10_23736_S0391_1977_18_02890_0 crossref_primary_10_1515_cclm_2018_0824 crossref_primary_10_1097_PCC_0b013e3181f36d17 crossref_primary_10_1177_0009922812462235 crossref_primary_10_1507_endocrj_EJ16_0242 crossref_primary_10_1002_hep_25573 crossref_primary_10_1002_pbc_24095 crossref_primary_10_1200_JCO_2014_56_7933 crossref_primary_10_1056_NEJMc091331 crossref_primary_10_1111_j_1365_2265_2011_04130_x crossref_primary_10_1016_j_beem_2020_101379 crossref_primary_10_1016_j_jpeds_2015_11_026 crossref_primary_10_1210_jc_2019_00304 crossref_primary_10_1111_apt_12891 crossref_primary_10_4158_EP171861_OR crossref_primary_10_1210_jc_2012_3576 crossref_primary_10_1097_QAI_0b013e31829260d6 crossref_primary_10_7599_hmr_2012_32_4_203 crossref_primary_10_1007_s11102_010_0270_3 crossref_primary_10_1016_j_bbadis_2018_08_001 crossref_primary_10_1002_pbc_28349 crossref_primary_10_1210_jc_2009_2697 crossref_primary_10_1155_2018_1739831 crossref_primary_10_1016_j_jhep_2010_06_034 crossref_primary_10_1186_s12902_024_01546_z crossref_primary_10_1210_jendso_bvaa079 crossref_primary_10_1136_postgradmedj_2020_138514 crossref_primary_10_1016_S0140_6736_13_61684_0 crossref_primary_10_1210_clinem_dgaa635 crossref_primary_10_1530_EJE_09_0746 crossref_primary_10_1111_liv_15473 crossref_primary_10_1016_j_jpeds_2010_08_021 crossref_primary_10_1111_petr_14768 crossref_primary_10_1007_s12020_017_1298_1 crossref_primary_10_1159_000351705 crossref_primary_10_1007_s13631_016_0135_5 crossref_primary_10_1093_ejendo_lvae029 crossref_primary_10_1016_j_revmed_2012_12_001 crossref_primary_10_1097_XCE_0000000000000250 crossref_primary_10_2147_CMAR_S224791 crossref_primary_10_36290_vnl_2024_001 crossref_primary_10_1371_journal_pone_0068713 crossref_primary_10_1186_s13223_016_0154_9 crossref_primary_10_4158_EP10262_RA crossref_primary_10_1097_MPG_0000000000002537 crossref_primary_10_1111_apt_14573 crossref_primary_10_5812_ijp_90891 crossref_primary_10_1002_pbc_22208 crossref_primary_10_3805_eands_10_11 crossref_primary_10_1111_j_1365_2265_2011_04080_x crossref_primary_10_4158_EP09153_OR crossref_primary_10_1016_j_beem_2018_03_012 crossref_primary_10_1016_j_emc_2009_01_008 crossref_primary_10_1210_jendso_bvad127 crossref_primary_10_1159_000534317 crossref_primary_10_1111_cen_14499 crossref_primary_10_1210_jc_2010_0647 crossref_primary_10_1016_j_jaip_2014_04_008 crossref_primary_10_1111_cen_14934 crossref_primary_10_1007_s11102_024_01445_5 crossref_primary_10_1111_j_1651_2227_2009_01479_x crossref_primary_10_1136_archdischild_2015_308799 crossref_primary_10_2152_jmi_69_287 crossref_primary_10_1016_j_eprac_2024_10_009 crossref_primary_10_1155_2021_7137950 crossref_primary_10_1007_s12020_016_1042_2 crossref_primary_10_1097_QAD_0000000000002152 crossref_primary_10_1111_j_1440_1746_2012_07188_x crossref_primary_10_1093_nop_npac053 crossref_primary_10_1136_archdischild_2016_311223 crossref_primary_10_1530_EJE_10_0621 crossref_primary_10_3389_fneur_2020_551923 crossref_primary_10_1007_s11102_015_0643_8 crossref_primary_10_1530_EJE_09_0930 crossref_primary_10_1007_s40618_017_0788_6 crossref_primary_10_1007_s40618_024_02304_7 crossref_primary_10_1210_jc_2016_2118 crossref_primary_10_1007_s12020_014_0494_5 crossref_primary_10_1136_bmj_2021_065137 crossref_primary_10_1097_MED_0000000000000473 crossref_primary_10_1111_cen_13509 crossref_primary_10_1186_1710_1492_9_30 crossref_primary_10_1016_j_cgh_2013_08_028 crossref_primary_10_1007_s11102_011_0360_x crossref_primary_10_1002_jppr_1730 crossref_primary_10_1007_s11739_015_1308_3 crossref_primary_10_1136_bmjpo_2019_000569 crossref_primary_10_1210_jendso_bvac043 crossref_primary_10_1515_jpem_2022_0444 crossref_primary_10_1155_2022_7860272 crossref_primary_10_1080_24725625_2019_1569798 crossref_primary_10_1111_cen_15125 crossref_primary_10_1515_jpem_2014_0097 crossref_primary_10_1016_j_beem_2011_10_009 crossref_primary_10_1056_EVIDoa2200182 crossref_primary_10_1210_jc_2010_0982 crossref_primary_10_1093_pch_pxab015 crossref_primary_10_1093_pch_pxab016 crossref_primary_10_1007_BF03346560 crossref_primary_10_1507_endocrj_EJ15_0587 crossref_primary_10_1186_s13052_023_01475_y crossref_primary_10_1111_cen_12534 crossref_primary_10_1111_cen_12655 crossref_primary_10_1155_2019_7251010 crossref_primary_10_1111_cen_13063 crossref_primary_10_1007_s12020_013_9893_2 crossref_primary_10_1093_ejendo_lvad137 crossref_primary_10_1159_000504539 crossref_primary_10_1136_rmdopen_2018_000700 crossref_primary_10_1007_s12020_017_1330_5 crossref_primary_10_1210_jc_2016_3990 crossref_primary_10_1016_j_ando_2012_11_014 crossref_primary_10_1007_s40618_022_01926_z crossref_primary_10_3390_endocrines1020012 crossref_primary_10_1530_EJE_15_0182 crossref_primary_10_1007_s00381_013_2334_y crossref_primary_10_1111_j_1399_3046_2010_01466_x crossref_primary_10_1371_journal_pone_0166077 crossref_primary_10_2147_PHMT_S334576 crossref_primary_10_1093_rheumatology_keaa011 crossref_primary_10_1001_jamaophthalmol_2020_3322 crossref_primary_10_1210_jc_2010_0205 crossref_primary_10_1016_j_lpm_2014_01_007 crossref_primary_10_1530_EJE_13_0159 crossref_primary_10_1002_lary_31824 crossref_primary_10_3390_biomedicines11030904 crossref_primary_10_3389_fendo_2021_720769 crossref_primary_10_1007_s11926_015_0513_4 crossref_primary_10_1530_EJE_15_0608 crossref_primary_10_1136_jclinpath_2021_207895 crossref_primary_10_1016_j_athoracsur_2017_01_111 crossref_primary_10_1111_cen_13405 crossref_primary_10_1177_0004563216687335 crossref_primary_10_1210_clinem_dgae250 crossref_primary_10_4158_EP10011_RA crossref_primary_10_1016_j_jpeds_2010_07_004 crossref_primary_10_1016_j_medici_2014_10_006 crossref_primary_10_3390_jcm4081536 crossref_primary_10_1080_22201009_2011_10872256 crossref_primary_10_1111_cen_14887 crossref_primary_10_1016_j_pcl_2020_08_001 crossref_primary_10_5507_bp_2024_033 crossref_primary_10_3389_fendo_2021_686317 crossref_primary_10_4158_ACCR_2017_0187 crossref_primary_10_1080_00207454_2020_1815734 crossref_primary_10_1111_cen_13559 crossref_primary_10_1097_MD_0000000000022621 crossref_primary_10_1093_pch_pxy174 crossref_primary_10_1097_MED_0b013e328339f31e crossref_primary_10_1297_cpe_2022_0083 crossref_primary_10_1016_j_endoen_2014_02_004 crossref_primary_10_1016_j_ando_2012_03_031 crossref_primary_10_1007_s40618_024_02461_9 crossref_primary_10_1016_j_med_2020_09_004 crossref_primary_10_1136_rmdopen_2024_005251 crossref_primary_10_1016_j_eprac_2025_02_018 crossref_primary_10_1097_MPG_0000000000000848 crossref_primary_10_1016_j_jcf_2019_08_023 crossref_primary_10_1016_j_steroids_2018_01_009 crossref_primary_10_4158_EP_2017_0074 crossref_primary_10_1007_s40746_018_0126_z crossref_primary_10_1111_cen_14071 crossref_primary_10_1097_MEG_0000000000002153 crossref_primary_10_1002_acr_23123 crossref_primary_10_4137_CGast_S18127 crossref_primary_10_1111_cen_14300 crossref_primary_10_1111_j_1445_5994_2011_02582_x crossref_primary_10_1007_s12020_017_1505_0 crossref_primary_10_1530_EJE_13_0084 crossref_primary_10_1007_s12020_021_02701_5 crossref_primary_10_1186_s12902_016_0117_7 crossref_primary_10_1016_j_jpeds_2011_05_054 crossref_primary_10_1210_clinem_dgaa540 crossref_primary_10_1097_MPG_0000000000000877 crossref_primary_10_1002_pbc_27631 crossref_primary_10_1007_s11102_023_01368_7 crossref_primary_10_1016_j_med_2016_06_014 crossref_primary_10_1515_jpem_2020_0219 crossref_primary_10_1515_jpem_2022_0074 crossref_primary_10_20945_2359_4292_2022_0207 crossref_primary_10_1016_j_ando_2017_10_005 crossref_primary_10_1007_s40618_017_0691_1 crossref_primary_10_1530_EJE_09_0646 crossref_primary_10_3389_fendo_2022_925378 crossref_primary_10_1016_j_wneu_2022_09_006 crossref_primary_10_1016_j_heliyon_2022_e09559 crossref_primary_10_1007_s00101_022_01088_w crossref_primary_10_1016_S1637_5017_10_72467_4 crossref_primary_10_1111_cen_12235 crossref_primary_10_1530_EJE_12_0534 crossref_primary_10_3390_diagnostics11040728 crossref_primary_10_1016_j_eprac_2021_12_015 crossref_primary_10_1136_archdischild_2019_318431 crossref_primary_10_1210_jc_2019_00295 crossref_primary_10_1530_EJE_10_0229 crossref_primary_10_1159_000368318 crossref_primary_10_1177_11795514221093316 crossref_primary_10_1186_s12967_014_0340_9 crossref_primary_10_1210_clinem_dgac151 crossref_primary_10_14712_23362936_2016_2 crossref_primary_10_1530_EJE_09_0775 crossref_primary_10_3389_fendo_2021_727628 crossref_primary_10_1016_j_beem_2018_05_010 crossref_primary_10_1007_s40618_020_01292_8 crossref_primary_10_1183_13993003_01147_2019 crossref_primary_10_1210_clinem_dgaa323 crossref_primary_10_1111_liv_12820 crossref_primary_10_2174_1874306401408010093 crossref_primary_10_1016_j_jtcvs_2016_11_030 crossref_primary_10_1007_s11154_024_09877_x crossref_primary_10_1016_j_anai_2016_05_028 crossref_primary_10_2174_1573396315666191026100643 crossref_primary_10_1016_j_wneu_2021_06_098 crossref_primary_10_1186_1710_1492_7_13 crossref_primary_10_1038_nrendo_2016_45 crossref_primary_10_1016_j_dld_2015_08_006 crossref_primary_10_1016_j_jclinane_2013_07_002 crossref_primary_10_1007_s40618_023_02062_y crossref_primary_10_1055_a_2180_7108 crossref_primary_10_1111_j_1365_2265_2011_04313_x crossref_primary_10_1016_j_cgh_2011_03_033 crossref_primary_10_1080_17446651_2021_1979393 crossref_primary_10_1016_S1245_1789_10_70166_9 crossref_primary_10_2147_DMSO_S309641 crossref_primary_10_1210_clinem_dgaa793 crossref_primary_10_1210_endrev_bnae016 crossref_primary_10_1002_pbc_25780 crossref_primary_10_1111_cen_12373 crossref_primary_10_53730_ijls_v8nS1_15478 crossref_primary_10_1016_j_radonc_2011_02_015 crossref_primary_10_1111_j_1742_1241_2010_02466_x |
ContentType | Journal Article |
Copyright | Copyright © 2008 by The Endocrine Society 2008 Copyright © 2008 by The Endocrine Society 2008 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2008 by The Endocrine Society 2008 – notice: Copyright © 2008 by The Endocrine Society – notice: 2008 INIST-CNRS |
CorporateAuthor | Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency |
CorporateAuthor_xml | – name: Consortium for Evaluation of Corticotropin Test in Hypothalamic-Pituitary Adrenal Insufficiency |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 |
DOI | 10.1210/jc.2008-0710 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Nucleic Acids Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | 4253 |
ExternalDocumentID | 18697868 20849678 10_1210_jc_2008_0710 00004678-200811000-00017 10.1210/jc.2008-0710 |
Genre | Meta-Analysis Journal Article |
GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABDFA ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABVGC ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AHMMS AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 D-I DAKXR DIK E3Z EBS EJD EMOBN ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 HZ~ H~9 KBUDW KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN W8F WOQ X7M YBU YFH YHG YOC YSK ZY1 ~02 ~H1 .GJ 3O- 7X7 88E 8FI 8FJ AAJQQ AAKAS AAPGJ AAQQT AAUQX AAWDT AAYJJ ABDPE ABUWG ABXZS ACFRR ACVCV ACZBC ADMTO ADNBA ADZCM AEMQT AEOTA AFFQV AFKRA AFYAG AGMDO AGORE AHGBF AI. AJBYB AJDVS ALXQX APJGH AQDSO AQKUS AVNTJ BENPR BPHCQ BVXVI CCPQU EIHJH FEDTE FYUFA HMCUK HVGLF IAO IHR INH ITC J5H M1P MBLQV NU- OBFPC PHGZM PHGZT PQQKQ PROAC PSQYO TMA UKHRP VH1 WHG X52 ZGI ZXP AAYXX CITATION IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7QP 7T5 7TM H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4907-4d418fbd248d9cbf85f70c4bddce6cea86be1644125f109ea363911542f649683 |
ISSN | 0021-972X |
IngestDate | Thu Jul 10 23:03:41 EDT 2025 Mon Jun 30 12:40:43 EDT 2025 Mon Jul 21 06:00:52 EDT 2025 Mon Jul 21 09:16:04 EDT 2025 Tue Jul 01 04:01:28 EDT 2025 Thu Apr 24 22:54:04 EDT 2025 Fri May 16 04:03:13 EDT 2025 Fri Feb 07 10:35:25 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Obesity Nutrition Hypothalamohypophysoadrenal axis Peptide hormone Nutrition disorder Exploration Metabolic diseases Metaanalysis Adrenocorticotropic hormone Adenohypophyseal hormone Corticotropin Endocrinology Nutritional status |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4907-4d418fbd248d9cbf85f70c4bddce6cea86be1644125f109ea363911542f649683 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 18697868 |
PQID | 3164413831 |
PQPubID | 2046206 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_69753532 proquest_journals_3164413831 pubmed_primary_18697868 pascalfrancis_primary_20849678 crossref_citationtrail_10_1210_jc_2008_0710 crossref_primary_10_1210_jc_2008_0710 wolterskluwer_health_00004678-200811000-00017 oup_primary_10_1210_jc_2008-0710 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2008-November |
PublicationDateYYYYMMDD | 2008-11-01 |
PublicationDate_xml | – month: 11 year: 2008 text: 2008-November |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States – name: Washington |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2008 |
Publisher | Oxford University Press Copyright by The Endocrine Society Endocrine Society |
Publisher_xml | – name: Oxford University Press – name: Copyright by The Endocrine Society – name: Endocrine Society |
References | 19047996 - Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):68-9 |
References_xml | – reference: 19047996 - Nat Clin Pract Endocrinol Metab. 2009 Feb;5(2):68-9 |
SSID | ssj0014453 |
Score | 2.4449866 |
SecondaryResourceType | review_article |
Snippet | Context: The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial.
Objective: Our objective was to... CONTEXT:The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. OBJECTIVE:Our objective was to... The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. Our objective was to compare standard-dose... Context: The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial. Objective: Our objective was to... The diagnostic value of tests for detecting hypothalamic-pituitary adrenal insufficiency (HPAI) is controversial.CONTEXTThe diagnostic value of tests for... |
SourceID | proquest pubmed pascalfrancis crossref wolterskluwer oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 4245 |
SubjectTerms | Adrenal Gland Diseases - diagnosis Adrenocorticotropic Hormone - blood Adrenocorticotropic Hormone - secretion Adult Biological and medical sciences Child Cosyntropin - pharmacology Endocrinopathies Fasting Feeding. Feeding behavior Fundamental and applied biological sciences. Psychology Glucocorticoids - adverse effects Humans Hydrocortisone - blood Hypoglycemia Hypothalamic Diseases - diagnosis Hypothalamo-Hypophyseal System Hypothalamus Medical sciences Pituitary Pituitary Diseases - diagnosis Reproducibility of Results ROC Curve Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology |
Title | Corticotropin Tests for Hypothalamic-Pituitary- Adrenal Insufficiency: A Metaanalysis |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-200811000-00017 https://www.ncbi.nlm.nih.gov/pubmed/18697868 https://www.proquest.com/docview/3164413831 https://www.proquest.com/docview/69753532 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSAgJIe4UxsgDPFVBuTiJw1tVNg1Yh4Ra1LfISWytrEtKLkLbr-ccx81FasXlJaoSy018vhyfE_v7DiFvvVDS0HaFyT0BCQpMUWbshIlJU47TgyfiAPnOs3P_dEE_L71l9ylbsUuq-H1ys5NX8j9WhXNgV2TJ_oNl207hBPwG-8IRLAzHv7LxNMdzeVUg62kMQWOl1BXGF9cbMABfY615c7Oq6lXFi2tzzJG2rVQ2ylpJRyDvsqE7X4mKcy1Q0g9YEUY9dYmWSCmyNAeHk3USTthDnK-3koToxPnNmtflJdc1-L7xsp0E2gh-UlQXddHt1f6-UsBsqGpTXlyJrNuIO4nTWiEMMvyf4NNmg48WTLP3eo4Yd4YEqpJ664ibUolbwNk9t4rLszv9PSSs6O-VFiVDMpbVzWvbtfzzr9HJ4uwsmh8v57fJHQfyCSx18fHTl3a5iVItV6rvSjMkkN7U73sQuzR8yPsbXsKoy6YKyq40Bdr8ynHnQ3mpiA-98GX-kDzQeYcxaUD0iNwS2WNyd6Z3VjwhiwGWDIUlA7Bk7MGSobFkDLD0weBGH0lPyeLkeD49NXXJDTOhoRXAK0ptJuPUoSwNk1gyTwZWQuM0TYSfCM78WNgYQjuetK1QcBciXFR0cqRPQ5-5z8hBlmfiBTESCT1J8BBBnEIE5DLppJ5LqSW5Ywtpj8h4O5hRovXosSzKOsK8FIY--pHoIqkw9CPyrm29aXRY9rQzwC77mphNk6OB0drGjsXgGQI2IodbK0b6DSsjVz22y1y48TftZfDFuMDGM5HXZeQjS91znRF53ti-uw8G15gPXZsDMEQN2zlSqTr8Nbo3hiqOSu7BDl7-8b9ekXvdC3ZIDqqiFq8hTq7iI4Xx31eNvy4 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Corticotropin+tests+for+hypothalamic-pituitary-+adrenal+insufficiency%3A+a+metaanalysis&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Kazlauskaite%2C+Rasa&rft.au=Evans%2C+Arthur+T&rft.au=Villabona%2C+Carmen+V&rft.au=Abdu%2C+Tariq+A+M&rft.date=2008-11-01&rft.issn=0021-972X&rft.volume=93&rft.issue=11&rft.spage=4245&rft_id=info:doi/10.1210%2Fjc.2008-0710&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |